Institutional Manager · CIK 0001728001
Athyrium Capital Management, LP
NEW YORK, NY · File #028-18509
Latest AUM
$8.7M
Positions
2
Top-10 Concentration
100.0%
Filings
8
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Sep 20242 pos · $8.7M
- 13F HOLDINGS REPORTQ/E Jun 20243 pos · $33.5M
- 13F HOLDINGS REPORTQ/E Mar 20243 pos · $72.8M
- 13F HOLDINGS REPORTQ/E Dec 20236 pos · $113.6M
- 13F HOLDINGS REPORTQ/E Sep 20237 pos · $154.1M
- 13F HOLDINGS REPORT (Amended)Q/E Jun 20238 pos · $279.1M
- 13F HOLDINGS REPORTQ/E Jun 20238 pos · $279.1M
- 13F HOLDINGS REPORTQ/E Mar 202311 pos · $237.9M
Top 2 Holdings — Sep 2024
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Biora Therapeutics Inc. | 74319F305 | 10,929,762 | $5.5M | 63.12% |
| 2 | PUMA BIOTECHNOLOGY INC | PBYI | 1,256,411 | $3.2M | 36.88% |